National Clinical Database feedback implementation for quality improvement of cancer treatment in Japan: from good to great through transparency by unknown




National Clinical Database feedback implementation for quality 
improvement of cancer treatment in Japan: from good to great 
through transparency
Mitsukazu Gotoh1,2 · Hiroaki Miyata1,2 · Hideki Hashimoto1,2 · Go Wakabayashi2 · 
Hiroyuki Konno1,2 · Shuichi Miyakawa3 · Kenichi Sugihara1 · Masaki Mori1 · 
Susumu Satomi1 · Norihiro Kokudo1 · Tadashi Iwanaka1 
Received: 13 January 2015 / Accepted: 26 January 2015 / Published online: 24 March 2015 
© The Author(s) 2015. This article is published with open access at Springerlink.com
Abbreviations
NCD  National Clinical Database
ACS NSQIP  The American College of Surgeons National 
Surgical Quality Improvement Program
ASA  American Society of Anesthesiologists
CNS  Central nervous system
COPD  Chronic obstructive pulmonary disease
DIC  Disseminated intravascular coagulation
JSS  The Japan Surgical Society
JSGS  The Japanese Society of Gastroenterologi-
cal Surgery
ROC  Receiver operating characteristic
SIRS  Systemic inflammatory response syndrome
SSI  Surgical site infection
Introduction
Until recently, no nationwide data on cancer were avail-
able in the field of gastroenterological surgery in Japan. In 
2006, the Japanese Society of Gastroenterological Surgery 
(JSGS) formed a committee to devise a database to track 
surgical patients treated in Japan over the 3 years from 2006 
to 2008, and reported relatively low mortality rates for the 
major surgical procedures [1, 2]. The JSGS acknowledged 
the importance of risk-adjusted surgical outcomes for accu-
rate comparisons and quality improvement; thus, in April, 
2010, it created the database as a subset of the National 
Clinical Database (NCD) of Japan with major support 
from the Japan Surgical Society (JSS). Eight other surgical 
professional societies, including the Japanese Society for 
Cardiovascular Surgery, the Japanese Society for Vascular 
Surgery, the Japanese Association for Thoracic Surgery, 
the Japanese Association for Chest Surgery, the Japanese 
Society of Pediatric Surgeons, the Japanese Breast Cancer 
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Society, the Japan Association of Endocrine Surgeons, and 
the Japanese Society of Thyroid Surgery, joined the NCD. 
Registrations began in 2011, since when more than 4100 
facilities have enrolled and over 4,000,000 cases have been 
registered over a 3-year period.
The gastroenterological section of the NCD collaborates 
with the American College of Surgeons National Surgical 
Quality Improvement Program (ACS-NSQIP) [3], which 
shares a similar goal of developing a standardized surgical 
database for quality improvement. The NSQIP was originally 
developed in the 1990s by the United States Veterans’ Health 
Administration and led to marked improvement in surgical 
quality [4]. The American College of Surgeons (ACS) initi-
ated the ACS-NSQIP in 2006 and demonstrated improved 
surgical outcomes across all participating hospitals in the 
private sector [5]. The core members of the NCD joined 
the meetings and seminars of the ACS-NSQIP and debated 
various aspects of clinical databases, such as data collection 
methods and public relations [3]. In addition, the NCD imple-
mented the same items as those of the ACS-NSQIP to conduct 
international cooperative studies. Reliable 30-day outcomes, 
including mortality and morbidity, serve as a quality improve-
ment catalyst for ACS-NSQIP-participating institutions. Risk 
adjustment is a key component of the ACS-NSQIP and most 
variables included in risk adjustment models focus on patient 
factors and comorbidities. In this article, we focused on the 
gastrointestinal surgery subset of the NCD. All cases are input 
with items representing the surgical performance in each spe-
cialty for the following eight procedures: esophagectomy 
(Eso), total/distal gastrectomy (TG/DG), right hemicolec-
tomy (RHC), low anterior resection (LAR), hepatectomy per-
formed for more than one segment apart from the lateral seg-
ment (Hx), pancreaticoduodenectomy (PD), and surgery for 
acute diffuse peritonitis (ADP). Risk models of mortality for 
each procedure were created using approximately 120,000 
cases registered in 2011, and each model has been accepted 
and published in peer-reviewed journals [6–13]. We review 
the results and discuss the future evolution of the NCD using 
these risk models in terms of the surgical quality improve-
ment program in Japan.
NCD data entry system
Submitting cases to the NCD is a prerequisite for all mem-
ber institutions of the JSS and JSGS, and only registered 
cases can be used for board certification [3]. To assure 
the traceability of data, the NCD continuously tracks per-
sons who approve data, persons in departments who are in 
charge of annual cases, and persons responsible for data 
entry, through its web-based data management system. The 
NCD also continuously validates data consistency through 
random site visits.
The NCD variables are almost identical to those applied 
in the ACS-NSQIP (http://www.site.acsnsqip.org/wp-con-
tent/uploads/2013/10/ACSNSQIP.PUF_.UserGuide.2012.
pdf#search=‘user+guide+for+the+2012+ACS+NS
QIP). The potential independent variables include patient 
demographics, pre-existing comorbidities, preoperative 
laboratory values, and perioperative data. The demographic 
variables include age, sex, smoking status, and drinking 
status. Patients were categorized according to whether 
they were brought to hospital directly, by ambulance. Gen-
eral factors such as the patient’s body mass index (BMI) 
and preoperative functional status, defined as independ-
ent, partially dependent, or totally dependent, according to 
their ability to perform activities of daily living (ADL) in 
the 30 days prior to surgery and immediately before sur-
gery, were also considered. We evaluated the physical sta-
tus classification by the American Society of Anesthesi-
ologists (ASA) and considered pre-existing comorbidities, 
including the cardiovascular status, respiratory status, renal 
status, hematological status, oncological status, preopera-
tive blood transfusion, chronic steroid use, ascites, sepsis, 
diabetes, open wound, and pregnancy. The laboratory 
parameters included in the analysis were the white blood 
cell count, hemoglobin level, hematocrit, platelet count, 
prothrombin time, and activated partial thromboplastin 
time, as well as the serum levels of albumin, total bilirubin, 
aspartate amino transferase, alanine aminotransferase, alka-
line phosphatase, urea nitrogen, creatinine, sodium, hemo-
globin A1c, and C-reactive protein. The length of surgery, 
intraoperative blood loss, amount of transfusion, and any 
accident during the operation were also considered.
Postoperative outcomes evaluated 30 days after surgery 
were categorized according to the Clavien and Dindo clas-
sification [14]. The outcomes included relaparotomy within 
30 days after surgery, wound events, anastomotic leak, res-
piratory events, urinary tract events, central nervous system 
events, cardiac events, other events, systemic sepsis, sepsis, 
systemic inflammatory response syndrome, and 24 other 
complications added by the NCD. For Hx procedures, the 
indications for surgery and resected subsegments (S1–S8) 
were included as preoperative variables to create risk mod-
els [9].
Outcome measures and statistical analysis
The outcome measures of this study were 30-day mortality 
and operative mortality. The former was defined as death 
within 30 days of surgery, regardless of the patient’s geo-
graphical location, even if the patient had been discharged 
from hospital. The latter was defined as death within the 
index hospitalization period, regardless of the length of 
hospital stay (up to 90 days), as well as any death after dis-
charge, up to 30 days after surgery. Data were randomly 
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assigned into two subsets that were split 80/20: the first, 
for model development, and the second, for validation. The 
two sets of logistic models (30-day mortality and operative 
mortality) were constructed for dataset development using 
step-wise selection of the predictors with a probability (p) 
value for inclusion of 0.05. A “goodness-of-fit” test was 
performed to assess how well the model could discriminate 
between patient survival and death. The receiver operat-
ing characteristic (ROC) curves for the 30-day and opera-
tive mortalities were created for the validation dataset. An 
ROC curve is a plot of a test’s true-positive rate (sensitivity) 
versus its false-positive rate (1—specificity). Model cali-
bration, being the degree to which the observed outcomes 
matched the predicted outcomes from the model across a 
group of patients, was examined by comparing the observed 
and predicted averages with each of 10 equally sized sub-
groups, arranged in the order of increasing patient risk.
Case number and participating hospitals for each 
procedure and mortality rates
The NCD is a nationwide project in cooperation with 
Japan’s board certification system in surgery, for which 
more than 1,200,000 surgical cases from over 3500 hos-
pitals were collected in 2011. The number of participating 
hospitals in the gastroenterological section was 2045 at 
the time of the analysis (July, 2012). Among these cases, 
approximately 120,000 were used to create the risk models. 
Table 1 lists the number of cases for each procedure and the 
number of hospitals performing the respective procedure 
with its ratio to the total number of hospitals (%). Most 
procedures, except for ADP, were performed for cancer. 
Emergency surgery was most common for ADP (93 %). 
The 30-day mortality and operative mortality rates for the 
eight procedures were as follows: Eso, 1.2/3.4; TG, 0.9/2.3; 
DG, 0.5/1.2; RHC, 1.1/2.3; LAR, 0.4/0.9; HX, 2.0/4.0; PD, 
1.2/2.8; and ADP, 9.0/14.1 %, respectively (Table 1). The 
operative mortality for each procedure, apart from ADP, 
was more than twice that of the 30-day mortality.
Risk models in the eight procedures
The 30-day mortality and operative mortality risk mod-
els for the eight procedures were created, and the C-index 
for those in the validation data sets was as follows: Eso, 
0.767/0.742; TG, 0.811/0.824; DG, 0.785/0.798; RHC, 
0.836/0.854; LAR, 0.75/0.766; HX, 0.714/0.761; PD, 
0.675/0.725; and ADP, 0.851/0.852, respectively (Tables 2, 
3). The final logistic models for the 30-day mortality with 
odds ratios for the eight procedures are listed in Table 2. 
Age; sex; emergency surgery; ADL; ASA class; BMI; car-
diovascular, pulmonary, and renal comorbidities; and other 
patient conditions such as disseminated cancer, ascites, pre-
operative transfusion, bleeding disorder, diabetes, weight 
loss, sepsis, and chronic steroid use, including 121 vari-
ables, were found to be risk factors for certain procedures. 
Age, ADL ASA, BMI, disseminated cancer, bleeding disor-
der, and weight loss appeared to be common risk factors in 
most of the procedures. Table 3 lists the final logistic mod-
els for the operative mortality with odds ratios for the eight 
procedures, including 159 variables. New and additional 38 
variables were captured for these models.
Feedback implementation (risk calculator)
A risk-adjusted analysis based on nationwide data allows 
personnel to establish and provide feedback on the risks 
that patients face before undergoing a procedure. On 
the basis of these objective data, healthcare profession-
als can then determine the treatment indicators and obtain 
informed consent. The risk calculator for all eight proce-
dures will be available soon, on the websites of the hospi-
tals that are a part of NCD, although the calculators for TG, 
PD, Hx, Eso, RHC, and LAR are currently available (Feb-
ruary, 2015). The real-time feedback system gives the pre-
dicted mortality of patients simultaneously with data input. 
Standardized information on patient risk and predicted 
mortality can be reformulated as case reports and shared at 
conferences.
Table 1  Registered cases used to create risk models for 8 surgical procedures [6–13]
Esophagectomy (Eso), total/distal gastrectomy (TG/DG), right hemicolectomy (RHC), low anterior resection (LAR), hepatectomy performed for 
>1 segment except for the lateral segment (Hx), pancreaticoduodenectomy (PD), and operation for acute diffuse peritonitis (ADP)
Eso TG DG RHC LAR Hx PD ADP
Registered cases 5354 20,011 33,917 19,070 16,695 7732 8575 8482
Participating hospitals 713 1623 1737 1689 1620 987 1167 1285
(%) 34.9 79.4 84.9 82.6 79.2 48.3 57.1 62.8
30-day mortality (%) 1.2 0.9 0.5 1.1 0.4 2.0 1.2 9.0
Operative mortality (%) 3.4 2.3 1.2 2.3 0.9 4.0 2.8 14.1
Cancer surgery (%) 98.4 98.5 99.9 92.6 98.5 94.5 91.4 10.8
Emergent case (%) 0.8 2.0 0.9 8.4 1.1 0.8 0.9 92.9
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Table 2  Risk models for 
30-day mortality after 8 
gastrointestinal procedures (refs 
6–13)
Variables Eso TG DG RHC LAR Hx PD ADP
Age category 1.5 1.2 1.2 1.3 1.4 1.3 1.2
Male sex 1.6 2.0
Ambulance transport 1.4
Emergent surgery 1.9 3.8 4.3
ADL within 30 days before surgery
 Any assistance 4.2 2.1
 Total 3.0
ADL immediately before surgery
 Any assistance 2.1 2.8
 Total 1.4
ASA
 Class 3 2.3 2.7
 Class 4 4.3
 Class 5 8.7
 Class 3, 4, 5 2.0 2.0 2.2
 Class 4, 5 9.4 4.0
BMI
 >25 kg/m2 2.4
 >30 kg/m2 7.0
Congestive heart failure 2.3
Previous cardiac surgery 2.3
Myocardial infarction 3.1
Previous PCI 2.0





Acute renal failure 3.2
Preoperative dialysis 3.9
Cancer with multiple metastases 2.2
Disseminated cancer 2.6 4.9 2.2
Preoperative transfusion 1.9 5.4 1.6
Bleeding disorder without treatment 3.2 5.2 1.6
Bleeding disorder 4.4
Diabetes 2.2
Smoking within 1 year 2.6
Ascites 2.0 2.1
 Without control 3.0
Chronic steroid use 1.7
Weight loss 2.4 2.3
Sepsis 2.0
Habitual alcohol consumption 1.6
WBC
 >12,000/μl 3.7 3.7
 >9000/μl 1.5
 <4000/μl 2.8 1.4
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Table 2  continued Variables Eso TG DG RHC LAR Hx PD ADP
Hemoglobin
 M < 13.5 g/dl, F < 12.5 g/dl 1.7 1.8




 <120,000/μl 1.9 5.0 1.7
 <80,000/μl 3.1 1.5
 <50,000/μl 5.6
Albumin
 <4.0 g/dl 2.0 3.4
 <3.5 g/dl 1.7 1.5 2.0
 <2.0 g/dl 1.7
Total bilirubin
 >3.0 mg/dl 3.1 1.7
 >2.0 mg/dl 2.9
AST
 >35 U/l 2.3 3.1 2.3 1.4
ALP
 >600 U/l 2.5 1.7
 >340 U/l 1.7 2.2
BUN
 >25 mg/dl 1.9 2.5 1.4
 >20 mg/dl 1.8
 <8.0 mg/dl 2.3
Creatinine
 >2.0 mg/dl 3.9
 >1.2 mg/dl 1.8
Serum Na
 >145 mEq/l 1.7
 <138 mEq/l 2.1 3.6
 <135 mEq/l 3.6 2.5
 <130 mEq/l 1.7
CRP
 <10.0 mg/dl 1.5
APTT
 >40 s 3.2
PT-INR
 >1.25 2.2 2.0
 >1.1 2.0 1.5 1.7
Non-tumor bearing 0.6
Surgical procedures #1
Indication for surgery #2
#1 Hepatectomy with S8 (2.2), hepatectomy with revascularization (3.8)
#2 Hilar bile duct carcinoma (2.5), gallbladder cancer (4.1)
ADL, Activities of daily living, PT-INR Prothrombin time-international normalized ratio, WBC white blood 
cells, ASA American society of anesthesiologists, ADL activities of daily living, PCI percutaneous coronary 
intervention, COPD chronic obstructive pulmonary disease, AST aspartate amino transferase, ALP alkaline 
phosphatase, APTT activated partial thromboplastin time
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Table 3  Risk models for 
operative mortality after 8 
gastrointestinal procedures 
[6–13]
Variables Eso TG DG RHC LAR Hx PD ADP
Age category 1.4 1.3 1.3 1.1 1.4 1.4 1.3 1.3
Male sex 2.3 1.9 1.5
Emergent surgery 1.7 1.9 1.9 2.8
ADL within 30 days before surgery
 Any assistance 4.7 2.8 2.5
 Total 1.6
ADL immediately before surgery
 Any assistance 2.0 2.5 2.5 1.4
 Total 3.0 2.9
ASA
 Class 3 1.8 1.6 2.3
 Class 4 4.7
 Class 5 6.5
 Class 3, 4, 5 1.9 2.0 2.1
 Class 4, 5 5.2 2.9
BMI
 >25 kg/m2 1.9
 >30 kg/m2 4.6
Congestive heart failure 2.2
Angina 2.6




 Any 1.7 2.4 2.9 2.4
COPD 2.1 2.0
Preoperative pneumonia 3.8 1.4
Preoperative dialysis 2.6 2.1
Cancer metastasis/relapse 4.5 1.6
Disseminated cancer 3.5 2.9 3.1 2.8 2.1
Preoperative transfusion 2.6 1.8
Bleeding disorder without therapy 1.6
Brinkman index 1.6
Ascites
 Any 1.8 1.6 4.0 1.9
 Without control 2.8
Chronic steroid use 2.8 2.0 1.9
Weight loss 2.0 1.6 2.2 1.6 2.1 1.4
Sepsis 1.7
WBC
 >11,000/μl 2.0 2.5 3.1
 >9000/μl 1.6
 <4500/μl 1.8 1.5
 <3500/μl 1.6
Hemoglobin
 M < 13.5 g/dl, F < 12.5 g/dl 2.6 1.3
 <10 g/dl 1.8
Hematocrit
 M > 48 %, F > 42 % 3.6
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Table 3  continued Variables Eso TG DG RHC LAR Hx PD ADP
 M < 37 %, F < 32 % 1.4 1.4
 <30 % 1.3 1.2
Platelet
 <120,000/μl 2.0 2.0 1.7 3.4 1.6 2.1 1.4
 <80,000/μl 2.6 2.1
Albumin
 <3.8 g/dl 1.7
 <3.5 g/dl 2.2 1.4 1.6
 <3.0 g/dl 1.4 1.5 1.7 1.4
 <2.5 g/dl 2.7
 <2.0 g/dl 1.5
Total bilirubin
 >3.0 mg/dl 2.0
 >2.0 mg/dl 2.8 2.6
 >1.0 mg/dl 1.6
AST
 >40 U/l 1.5 2.7 1.9 1.7
 >35 U/l 1.7 1.4
ALP
 >600 U/l 3.1 1.6
 >340 U/l 1.6
BUN
 >60 mg/dl 2.4
 >25 mg/dl 1.3
 >20 mg/dl 1.8
 <8 mg/dl 2.6 1.6
Creatinine
 >2.0 mg/dl 1.5
 >1.2 mg/dl 1.8
Serum Na
 >145 mEq/l 1.9
 <138 mEq/l 2.1 1.4 1.9 2.5
 <135 mEq/l 2.3
 <130 mEq/l 1.8
CRP
 <10.0 mg/dl 1.5
APTT
 >40 s 1.6 2.0
PT-INR
 >1.25 3.0 1.9
 >1.1 1.5 1.4 1.4 1.5
Non-tumor bearing 0.5
Surgical procedure #1 #2
indication for surgery #3
#1 Pancreatico splenectomy (2.2)
#2 Hepatectomy with S1 (1.6), S7 (1.6), S8 (2.0), left tri-segmentectomy with S1 resection (3.9), hepatec-
tomy with revascularization (3.0)
#3 Intrahepatic cholangiocarcinoma (1.8), hilar bile duct carcinoma (2.0), gallbladder cancer (3.2)
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The NCD will soon be able to provide data on each 
facility’s severity-adjusted clinical performance (bench-
mark), which can be compared with national data (Fig. 1a). 
Cumulative observed–expected mortality can be traced 
periodically after each operation and used to detect special 
cause variations showing better (right) and worse (left) out-
comes (Fig. 1b).
Future evolution of NCD
A complete data acquisition system link to board 
certification
More than 4,000,000 cases were retrieved from the NCD 
during the 3 years before April 2013. The number of 
esophagectomy and pneumonectomy cases registered in 
the NCD accounted for approximately 95 % of all cases 
registered in the Regional Bureau of Health and Welfare. 
Thus, most cases in Japan appear to be captured by the 
NCD system. This NCD project started with support from 
Health and Labor Sciences Research Grants by the Minis-
try of Health Labour and Welfare (Principal Investigators; 
MG, T.I.) and considerable funding from the JSGS and 
JSS. Participating institutions can now use the database 
system at no cost; however, it is mandatory for the insti-
tutions to participate in the benchmarking project when 
applying for the board certification system. Currently, the 
board certification system is operating adequately on the 
web for surgical society members and allows members to 
obtain information on their cases being used to assess a 
member’s qualifications for certification during a certain 
period. Any applicant who has a sufficient number of 
cases for application no longer needs to write case reports. 
All participating healthcare professionals use informa-
tion acquired from the NCD. Moreover, the board certifi-
cation system itself can be revalidated using the surgical 
improvement program of the NCD.
Share benefits and costs of the NCD with relevant 
stakeholders
A previous study by Hall et al. [5] showed that participa-
tion in the benchmark reporting system of the ACS-NSQIP 
improved surgical outcomes across all participating hospi-
tals in the private sector. Improvement is reflected for both 
poor- and well-performing facilities. They speculated in the 
model using 183 participating hospitals that each institu-
tion may have avoided 200–500 complications and 12–36 
deaths. Participation in the ACS-NSQIP benefits patients, 
surgeons, and hospitals and costs 10,000–29,000 (US$) 
depending on the ACS-NSQIP options [15.]
In the gastroenterological section, risk models of mor-
tality for the eight procedures were created to enable feed-
back. Simultaneously, risk models of morbidities for the 
eight procedures are being created to enable feedback for 
the next year. Currently, the database system is built up 
to enable efficient provision of benchmark reports to each 
institute. The benefits and costs can now be shared with the 
relevant stakeholders. A participation fee depending on the 
number of cases for retrieval is expected to be charged by 
the NCD to each hospital. Research grants from various 
sources are also expected to support clinical investigations 
using the NCD data.
Fig. 1  The National Cancer 
Database feedback system 
includes a risk calculator for the 
mortality and morbidity of pre-
operative patients (left schema) 
and performance reports of 
each participating hospital 
(right schema). The latter 
includes each facility’s severity-
adjusted clinical performance 
(benchmark) in comparison 
with the national data (a) and 
the risk-adjusted cumulative 
expected–observed death (b). 
Better (right) or worse (left) 
outcomes can be detected by the 
monitoring report
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Eliminating burden on physicians and maintaining data 
accuracy
To avoid burdening physicians, the NCD allows data entry 
by other medical staff members. The NCD data entry 
privileges allow people other than physicians to enter the 
data. An appropriate educational system for data managers 
would be mandatory to maintain the accuracy of data and 
reduce the burden on physicians. This could be achieved by 
holding an annual data manager educational meeting and 
eventually introducing an e-learning system. The JSGS is 
planning to create an audit committee separately from the 
NCD, with the goal of achieving accurate data inputs and 
of educating data managers.
Quality improvement of surgical care for cancer 
patients
The NCD generalizes site-specific cancer registries by tak-
ing advantage of their excellent organizing ability. Some 
site-specific cancer registries have already been combined 
with the NCD [16]. Cooperation between the NCD and 
site-specific cancer registries can establish a valuable plat-
form upon which a cancer care plan can be developed in 
Japan. Furthermore, information on the prognosis of can-
cer patients gathered using population- and hospital-based 
cancer registries can enable efficient data accumulation into 
the NCD.
Currently, quality assessment of hospitals is being car-
ried out using the Diagnosis Procedure Combination (DPC) 
data from the participating hospitals [17, 18]. The DPC 
data include variables for preoperative morbidities, cancer 
variables, and postoperative complications, but they are 
based mainly on administrative claim data. A low participa-
tion rate by very small hospitals in the DPC system cov-
ers 50% of institutions conducting surgical services [17] 
and hampers complete enumeration. The NCD is a quality 
assessment and improvement program in which clinical 
data are used with a high collection rate (95 %). Site-spe-
cific cancer registries in the NCD would not only be more 
accurate and suitable for perioperative assessment, but also 
for long-term outcomes of cancer patients.
Further improvements through transparency
Public reporting and transparency are being demanded 
by multiple stakeholders [19, 20]. Although it has been 
shown that performance data released to the public 
promote quality improvement activity at the hospital 
level [21, 22], opponents counter that public report-
ing induces gaming and other unintended consequences 
such as “cherry picking” (hospitals selecting lower-risk 
patients to avoid poorer outcomes) or losing patients to 
better-performing hospitals [23]. With the consent of 
participating surgical societies, the NCD stated that the 
performance of each institute would be fed back only to 
respective institutes but not to the general public. This 
practice is similar to that of the ACS-NSQIP, from which 
a report is prepared for administrators and surgical ser-
vices staff to compare their risk-adjusted surgical out-
comes with those of participating sites that are blinded to 
data other than their own.
In 2012, the ACS-NSQIP partnered with the Centers 
for Medicare and Medicaid Services (CMS) to promote 
public reporting and transparency of surgical outcomes 
[24]. Although there were few measurable differences 
between CMS-NSQIP-participating and CMS-NSQIP-
nonparticipating hospitals, it was found that of all pos-
sible hospital structural characteristics, only the teaching 
hospital status predicted participation in the CMS-NSQIP 
public reporting initiative. It may be a challenge for 
participating hospitals to show their performance to the 
general public. There is an interesting study by Sherman 
et al. [25, who investigated surgeons’ perceptions of pub-
lic reporting of hospital and individual surgeon quality. 
They stated that surgeons recommended patient educa-
tion, simplified data presentation, and continued risk-
adjustment refinement, and conducted an internal review 
before public reporting to make public reporting more 
acceptable for them. Linkage between hospital informa-
tion systems and the NCD registry system may improve 
data accuracy and save costs. Presentation of care quality 
is increasingly regarded as imperative to support patients’ 
choice and efficiency of care provision. We want medical 
professionals to realize that good to great performance 
can be achieved only through transparency for providers 
and patients.
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